Olanzapine plus fluoxetine for bipolar disorder: A systematic review and meta-analysis

Journal of Affective Disorders

Volumn 146, Issue 3, 2013, Pages 310-318

  Silva, Marcus T ^a   Zimmermann, Ivan R ^a   Galvao, Tais F ^a,b   Pereira, Mauricio G ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

Author keywords

Bipolar disorder; Depression; Meta analysis; Olanzapine fluoxetine combination

Indexed keywords

FLUOXETINE; FLUOXETINE PLUS OLANZAPINE; LAMOTRIGINE; OLANZAPINE; PLACEBO;

APPETITE; ATTENTION DISTURBANCE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; HOSPITAL ADMISSION; HUMAN; MANIA; META ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; REMISSION; REVIEW; SIDE EFFECT; SOMNOLENCE; SUICIDAL IDEATION; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DRUG COMBINATIONS; FLUOXETINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84875215392     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.11.001     Document Type: Review

References (57)

1. J.D. Amsterdam, and J. Shults Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression - lack of manic induction Journal of Affective Disorders 87 1 2005 121 130
2. H. Balshem, M. Helfand, H.J. Schünemann, A.D. Oxman, R. Kunz, J. Brozek, G.E. Vist, Y. Falck-Ytter, J. Meerpohl, S. Norris, and G.H. Guyatt GRADE guidelines: 3. Rating the quality of evidence Journal of Clinical Epidemiology 64 4 2011 401 406
3. F. Benazzi, M. Berk, M.A. Frye, W. Wang, A. Barraco, and M. Tohen Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis Journal of Clinical Psychiatry 70 10 2009 1424 1431
4. E. Brown, D.L. Dunner, S.L. McElroy, P.E. Keck, D.H. Adams, E. Degenhardt, M. Tohen, and J.P. Houston Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression International Journal of Neuropsychopharmacology 12 6 2009 773 782
5. E.B. Brown, S.L. McElroy, P.E. Keck Jr., A. Deldar, D.H. Adams, M. Tohen, and D.J. Williamson A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression Journal of Clinical Psychiatry 67 7 2006 1025 1033
6. S. Chinn A simple method for converting an odds ratio to effect size for use in meta-analysis Statistics in Medicine 19 22 2000 3127 3131
7. L. Citrome Olanzapine-fluoxetine combination for the treatment of bipolar depression Expert Opinion on Pharmacotherapy 12 17 2011 2751 2758
8. K.R. Connolly, and M.E. Thase The clinical management of bipolar disorder: a review of evidence-based guidelines The Primary Care Companion for CNS Disorders 13 2011 4
9. S.A. Corya, R.H. Perlis, P.E. Keck Jr., D.Y. Lin, M.G. Case, D.J. Williamson, and M.F. Tohen A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression Journal of Clinical Psychiatry 67 5 2006 798 806
10. J. De Fruyt, E. Deschepper, K. Audenaert, E. Constant, M. Floris, W. Pitchot, P. Sienaert, D. Souery, and S. Claes Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis Journal of Psychopharmacology 26 5 2012 603 617
11. E.D. Deeks, and G.M. Keating Olanzapine/fluoxetine: a review of its use in the treatment of acute bipolar depression Drugs 68 8 2008 1115 1137
12. M.P. DelBello, K.M. Cecil, C.M. Adler, J.P. Daniels, and S.M. Strakowski Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study Neuropsychopharmacology 31 6 2006 1264 1273
13. J.F. Goldberg, and L. Citrome Latest therapies for bipolar disorder. Looking beyond lithium Postgraduate Medical 117 2 2005 25 26, 29-32, 35-36
14. G.M. Goodwin Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British association for psychopharmacology Journal of Psychopharmacology 23 4 2009 346 388
15. G.M. Goodwin, Psychopharmacology, C.G.o.t.B.A.f., Evidence-based guidelines for treating bipolar disorder: revised second edition - recommendations from the British Association for Psychopharmacology Journal of Psychopharmacology 23 4 2009 346 388
16. H. Grunze, E. Vieta, G.M. Goodwin, C. Bowden, R.W. Licht, H.J. Möller, S. Kasper, and W.T.F.O.T.G.F.B. Disorders The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression' World Journal of Biological Psychiatry 11 2 2010 81 109
17. H.C. Grunze Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation? CNS Spectrums 13 9 2008 790 795
18. R.M. Harbord, M. Egger, and J.A. Sterne A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints Statistics in Medicine 25 20 2006 3443 3457
19. Higgins, J.Green, S. (2011) Cochrane Handbook for Systematic Reviews of Interventions, [online], available: 〈www.cochrane-handbook.org〉 (accessed 19 Sep 2012).
20. J. Houston, S. Dharia, J.R. Bishop, V.L. Ellingrod, B. Fijal, J.G. Jacobson, and V.P. Hoffmann Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women Psychiatry Research 187 1-2 2011 74 79
21. Houston, J.P., Degenhardt, E.L., Ahl, J., Easom, H.M., Kaiser, C. and Kinon, B.J. (2004) Suicidal Ideation Changes in Depressed Bipolar I Patients with Olanzapine-fluoxetine Combination, American Psychiatric Association, 157th Annual Meeting.
22. L.L. Judd, and H.S. Akiskal Depressive episodes and symptoms dominate the longitudinal course of bipolar disorder Current Psychiatry Reports 5 6 2003 417 418
23. L.L. Judd, P.J. Schettler, H.S. Akiskal, J. Maser, W. Coryell, D. Solomon, J. Endicott, and M. Keller Long-term symptomatic status of bipolar I vs. bipolar II disorders International Journal of Neuropsychopharmacology 6 2 2003 127 137
24. A. Karls, and C. Kraus Is olanzapine plus fluoxetine more effective than olanzapine alone for bipolar I depression? Evidence-Based Practice 12 2 2009 11-11
25. P.E. Keck Jr, S.A. Corya, L.L. Altshuler, T.A. Ketter, S.L. McElroy, M. Case, S.D. Briggs, and M. Toben Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression Journal of Clinical Psychiatry 66 5 2005 611 616
26. T.A. Ketter, P.W. Wang, C. Nowakowska, and W.K. Marsh New medication treatment options for bipolar disorders ACTA Psychiatrica Scandinavica 422 2004 18 33
27. R.W. Kupka, L.L. Altshuler, W.A. Nolen, T. Suppes, D.A. Luckenbaugh, G.S. Leverich, M.A. Frye, P.E. Keck, S.L. McElroy, H. Grunze, and R.M. Post Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder Bipolar Disorder 9 5 2007 531 535
28. R.W. Licht, H. Gijsman, W.A. Nolen, and J. Angst Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration ACTA Psychiatrica Scandinavica 118 5 2008 337 346
29. Lilly (2004) Summary ID#3077. Clinical Study Summary:Study F1D-MC-HGGY. Placebo-Controlled Olanzapine Monotherapy in the Treatment of Bipolar I Depression', available: 〈http://www.lillytrials.com/results/Symbyax. pdf〉 [accessed 19 Sep 2012].
30. Lilly (2006) Summary ID# 7980. Clinical Study Summary: Study H6P-US-HDAQ. Olanzapine/fluoxetine Combination versus Comparator in the Treatment of Bipolar I Depression, available: 〈http://www.lillytrials.com/results/Symbyax. pdf〉 [accessed 19 Sep 2012].
31. Lilly (2007) Summary ID# 9370. Clinical Study Summary: Study F1D-SU-HGMA.Study F1D-SU-HGMA: Bipolar depression assessment study on treatment response (BiDAS-TR), [online], available: 〈http://www.lillytrials.com/ results/Symbyax.pdf〉 (accessed 19 Sep 2012).
32. K. Linnavuori, and T. Hovi Herpes simplex virus as an inducer of interferon in human monocyte cultures Antiviral Research 8 4 1987 201 208
33. K. Madigan, P. Egan, D. Brennan, S. Hill, B. Maguire, F. Horgan, C. Flood, A. Kinsella, and E. O'Callaghan A randomised controlled trial of carer-focussed multi-family group psychoeducation in bipolar disorder European Psychiatry 27 4 2012 281 284
34. K.R. Merikangas, and F. Lamers The 'true' prevalence of bipolar II disorder Current Opinion in Psychiatry 25 1 2012 19 23
35. M.C. Miller Questions and answers. What is Symbyax, the new drug being marketed for the treatment of bipolar depression Harvard Mental Health Letter 21 2 2004 8
36. R.K. Morriss, F. Lobban, S. Jones, L. Riste, S. Peters, C. Roberts, L. Davies, and D. Mayes Pragmatic randomised controlled trial of group psychoeducation versus group support in the maintenance of bipolar disorder BMC Psychiatry 11 2011 114
37. A.M. Nivoli, F. Colom, A. Murru, I. Pacchiarotti, P. Castro-Loli, A. Gonzalez-Pinto, K.N. Fountoulakis, and E. Vieta New treatment guidelines for acute bipolar depression: a systematic review Journal of Affective Disorders 129 1-3 2011 14 26
38. S.V. Parikh, A. Zaretsky, S. Beaulieu, L.N. Yatham, L.T. Young, I. Patelis-Siotis, G.M. Macqueen, A. Levitt, T. Arenovich, P. Cervantes, V. Velyvis, S.H. Kennedy, and D.L. Streiner A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME] Journal of Clinical Psychiatry 73 6 2012 803 810
39. J.L. Peters, A.J. Sutton, D.R. Jones, K.R. Abrams, and L. Rushton Comparison of two methods to detect publication bias in meta-analysis Journal of the American Medical Association 295 6 2006 676 680
40. R.M. Post Bipolar Disorder in Adults D.S. Basow, Maintenance Treatment 2012 Waltham: UpToDate UpToDate
41. R.M. Post, L.L. Altshuler, G.S. Leverich, M.A. Frye, W.A. Nolen, R.W. Kupka, T. Suppes, S. McElroy, P.E. Keck, K.D. Denicoff, H. Grunze, J. Walden, C.M. Kitchen, and J. Mintz Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline British Journal of Psychiatry 189 2006 124 131
42. M. Reinares, F. Colom, J. Sanchez-Moreno, C. Torrent, A. Martinez-Aran, M. Comes, J.M. Goikolea, A. Benabarre, M. Salamero, and E. Vieta Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial Bipolar Disorder 10 4 2008 511 519
43. G.S. Sachs, C.L. Koslow, and S.N. Ghaemi The treatment of bipolar depression Bipolar Disorder 2 2000 256 260 3 Pt 2
44. Schünemann, H., Brożek, J. and Oxman, A. (2009) GRADE Handbook for Grading Quality of Evidence and Strength of Recommendation. Version 3.2, available: 〈http://ims.cochrane.org/gradepro〉 (accessed 19 Sep 2012).
45. L. Shi, M.A. Namjoshi, R. Swindle, X. Yu, R. Risser, R.W. Baker, and M. Tohen Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial Clinical Therapeutics 26 1 2004 125 134
46. K. Soares-Weiser, Y. Bravo Vergel, S. Beynon, G. Dunn, M. Barbieri, S. Duffy, J. Geddes, S. Gilbody, S. Palmer, and N. Woolacott A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder Health Technology Assessment 11 39 2007 iii-iv, ix-206
47. H.A. Swartz, and M.E. Thase Pharmacotherapy for the treatment of acute bipolar II depression: current evidence Journal of Clinical Psychiatry 72 3 2011 356 366
48. J.M. Tamayo, V.K. Sutton, M.A. Mattei, B. Diaz, H.H. Jamal, E. Vieta, C.A. Zarate Jr., I. Fumero, and M. Tohen Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico Journal of Clinical Psychopharmacology 29 4 2009 358 361
49. M.E. Thase, S.A. Corya, O. Osuntokun, M. Case, D.B. Henley, T.M. Sanger, S.B. Watson, and S. Dube A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder Journal of Clinical Psychiatry 68 2 2007 224 236
50. M. Tohen, J. Calabrese, E. Vieta, C. Bowden, A. Gonzalez-Pinto, D. Lin, W. Xu, and S. Corya Effect of comorbid anxiety on treatment response in bipolar depression Journal of Affective Disorders 104 1-3 2007 137 146
51. M. Tohen, E. Vieta, J. Calabrese, T.A. Ketter, G. Sachs, C. Bowden, P.B. Mitchell, F. Centorrino, R. Risser, R.W. Baker, A.R. Evans, K. Beymer, S. Dube, G.D. Tollefson, and A. Breier Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression Archives of General Psychiatry 60 11 2003 1079 1088
52. M.H. Trivedi, M.E. Thase, O. Osuntokun, D.B. Henley, M. Case, S.B. Watson, G.M. Campbell, and S.A. Corya An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression Journal of Clinical Psychiatry 70 3 2009 387 396
53. S. Van Dijk, J. Jeffrey, and M.R. Katz A randomized, controlled, pilot study of dialectical behavior therapy skills in a psychoeducational group for individuals with bipolar disorder Journal of Affective Disorders 2012
54. E. Vieta, M. Berk, W. Wang, F. Colom, M. Tohen, and R.J. Baldessarini Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients Journal of Affective Disorders 119 1-3 2009 22 27
55. E. Vieta, J. Locklear, O. Gunther, M. Ekman, C. Miltenburger, M.L. Chatterton, M. Astrom, and B. Paulsson Treatment options for bipolar depression: a systematic review of randomized, controlled trials Journal of Clinical Psychopharmacology 30 5 2010 579 590
56. D. Williamson, E. Brown, R.H. Perlis, J. Ahl, R.W. Baker, and M. Tohen Clinical relevance of depressive symptom improvement in bipolar I depressed patients Journal of Affective Disorders 92 2-3 2006 261 266
57. L.N. Yatham, S.H. Kennedy, A. Schaffer, S.V. Parikh, S. Beaulieu, C. O'Donovan, G. MacQueen, R.S. McIntyre, V. Sharma, A. Ravindran, L.T. Young, A.H. Young, M. Alda, R. Milev, E. Vieta, J.R. Calabrese, M. Berk, K. Ha, and F. Kapczinski Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009 Bipolar Disorder 11 3 2009 225 255.